VivoSim Labs, Inc.
VIVS
$2.11
$0.136.57%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -27.45% | 112.50% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -27.45% | 112.50% | |||
| Cost of Revenue | -98.49% | -51.80% | |||
| Gross Profit | 102.97% | 54.04% | |||
| SG&A Expenses | -16.84% | 37.19% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.89% | -8.22% | |||
| Operating Income | 7.58% | 9.05% | |||
| Income Before Tax | -141.49% | 298.78% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -141.49% | 298.78% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -141.49% | 298.78% | |||
| EBIT | 7.58% | 9.05% | |||
| EBITDA | 7.73% | 9.06% | |||
| EPS Basic | -126.95% | 269.79% | |||
| Normalized Basic EPS | 41.34% | 22.00% | |||
| EPS Diluted | -126.95% | 269.79% | |||
| Normalized Diluted EPS | 41.34% | 22.00% | |||
| Average Basic Shares Outstanding | 53.96% | -91.69% | |||
| Average Diluted Shares Outstanding | 53.96% | -91.69% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||